Fri, Aug 29, 2014, 11:22 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • faosto faosto Oct 18, 2012 3:08 PM Flag

    FDA Panel votes 9-6 in favor of ISIS mipomersen

    ... with one "weak yes vote". FDA will see this almost as an 8-7 vote which is very weak. I predict that the FDA will require additional data on tumor growth and fat buildup. This would have sailed through had there not been AEGR's drug the day before , which has a better safety profile and more efficacy. Any endocrinoligist prescribing a med will choose lomitapide first, Mipo second. Getting FDA approval on Mipo is by no means a slam dunk at this point. AEGR will be at 25 by Monday.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
30.55-0.09(-0.29%)Aug 29 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.